Cargando…
Coronavirus disease 2019 in Latin American patients with multiple sclerosis
Patients with multiple sclerosis (MS) who present coronavirus disease 2019 (COVID-19) are of particular interest to neurologists. These patients have a neuroimmune disease and receive immunomodulatory or immunosuppressive therapies in the long-term. We present here data from 73 patients with MS and...
Autores principales: | Fragoso, Yara D., Schiavetti, Irene, Carmisciano, Luca, Ponzano, Marta, Steinberg, Judith, Treviño-Frenk, Irene, Ciampi, Ethel, Vecino, Maria Cecilia A., Correa, Edgar P., Carcamo, Claudia, Gomes, Sidney, Pimentel, Maria Lucia V., Santos, Gutemberg A.C., Vrech, Carlos, Winckler, Thereza C.A., Sormani, Maria Pia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310568/ https://www.ncbi.nlm.nih.gov/pubmed/34332462 http://dx.doi.org/10.1016/j.msard.2021.103173 |
Ejemplares similares
-
Severe outcomes of COVID-19 among patients with multiple sclerosis under anti-CD-20 therapies: A systematic review and meta-analysis
por: Schiavetti, Irene, et al.
Publicado: (2022) -
Disease-modifying therapies in multiple sclerosis in Latin America
por: Skromne-Eisenberg, Eli, et al.
Publicado: (2017) -
COVID-19 severity among patients with multiple sclerosis treated with cladribine: A systematic review and meta-analysis
por: Albanese, Angela, et al.
Publicado: (2022) -
Practical Issues Concerning the Approval and Use of Biosimilar Drugs for the Treatment of Multiple Sclerosis in Latin America
por: Steinberg, Judith, et al.
Publicado: (2019) -
Quantitative assessment of finger motor performance: Normative data
por: Signori, Alessio, et al.
Publicado: (2017)